Supplementary Figure S10 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
openalex(2023)
摘要
Changes in ctDNA fraction and PSA levels between baseline and 4 weeks on-treatment in relation to the durability of response
更多查看译文
关键词
Metastatic Prostate Cancer,Prostate Cancer,Cancer,Tumor Evolution
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要